Biotechnology · Healthcare
Board Member
Since 2019-01-01, last confirmed 2020-08-07
Chase C. Leavitt
Equibles does not estimate personal net worth.
About Chase C. Leavitt
Chase C. Leavitt was last confirmed as Board Member at Lineage Cell Therapeutics, Inc. (LCTX) in a filing dated August 7, 2020. The proxy statement of Lineage Cell Therapeutics, Inc. reports total compensation of $752,952 for Chase C. Leavitt in fiscal 2020, including a base salary of $346,300. Disclosed compensation is on record for 2 fiscal years.
Affiliation history
-
2019-01-01–2020-08-07
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Lineage Cell Therapeutics, Inc. (LCTX) | Former General Counsel and Corporate Secretary | $346,300 | $752,952 |
| 2019 | Lineage Cell Therapeutics, Inc. (LCTX) | Former General Counsel and Corporate Secretary | $210,146 | $599,098 |
Recent activity
No call appearances or filed executive changes recorded yet.